Use of betablockers in post-myocardial infarction patients in a real-world setting.

Autor: Baviera M; Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy. Electronic address: marta.baviera@marionegri.it., Zanovello A; Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy., Ojeda-Fernández L; Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy., Molteni M; Internal Medicine, Tradate Hospital, Azienda Sociosanitaria Territoriale dei Settelaghi, Tradate VA, Italy., Cimminiello C; Arianna Foundation On Anticoagulation, Bologna, Italy.
Jazyk: angličtina
Zdroj: European journal of internal medicine [Eur J Intern Med] 2024 Dec 09. Date of Electronic Publication: 2024 Dec 09.
DOI: 10.1016/j.ejim.2024.12.005
Abstrakt: Competing Interests: Conflict of interest The authors declare no conflict of interest
Databáze: MEDLINE
Externí odkaz: